TACI attenuates antibody production costimulated by BAFF-R and CD40

European Journal of Immunology

Volumn 37, Issue 1, 2007, Pages 110-118

  Sakurai, Daisuke ^a   Kanno, Yumiko ^a   Hase, Hidenori ^a   Kojima, Hidefumi ^a   Okumura, Ko ^b   Kobata, Tetsuji ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

BAFF; BAFF R; CD40; Human; TACI

Indexed keywords

B LYMPHOCYTE ACTIVATING FACTOR OF THE TUMOR NECROSIS FACTOR RECEPTOR; B LYMPHOCYTE ACTIVATING FACTOR OF THE TUMOR NECROSIS FACTOR RECEPTOR MONOCLONAL ANTIBODY; CD40 ANTIGEN; CYTIDINE DEAMINASE; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; SYNAPSIN I; TRANSMEMBRANE ACTIVATOR AND CALCIUM MODULATOR AND CYCLOPHILIN LIGAND INTERACTOR; TRANSMEMBRANE ACTIVATOR AND CALCIUM MODULATOR AND CYCLOPHILIN LIGAND INTERACTOR MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ANTIBODY PRODUCTION; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL MIGRATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNOSTIMULATION; INHIBITION KINETICS; LYMPHOCYTE PROLIFERATION; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ADJUVANTS, IMMUNOLOGIC; ANTIBODIES, MONOCLONAL; ANTIBODY FORMATION; ANTIGENS, CD40; APOPTOSIS; B-CELL ACTIVATION FACTOR RECEPTOR; B-LYMPHOCYTE SUBSETS; CELL SURVIVAL; CELLS, CULTURED; DOWN-REGULATION; HUMANS; IMMUNE TOLERANCE; SIGNAL TRANSDUCTION; TRANSMEMBRANE ACTIVATOR AND CAML INTERACTOR PROTEIN; UP-REGULATION;

EID: 33846399188     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200636623     Document Type: Article

References (38)

1. Mackay, F., Schneider, P., Rennert, P. and Browning, J., BAFF AND APRIL: a tutorial on B cell survival. Annu. Rev. Immunol. 2003. 21: 231-264.
2. Groom, J., Kalled, S. L., Cutler, A. H., Olson, C., Woodcock, S. A., Schneider, P., Tschopp, J. et al., Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjogren's syndrome. J. Clin. Invest. 2002. 109: 59-68.
3. Khare, S. D., Sarosi, I., Xia, X. Z., McCabe, S., Miner, K., Solovyev, I., Hawkins, N. et al., Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice. Proc. Natl. Acad. Sci. USA 2000. 97: 3370-3375.
4. Mackay, F., Woodcock, S. A., Lawton, P., Ambrose, C., Baetscher, M., Schneider, P., Tschopp, J. and Browning, J. L., Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J. Exp. Med. 1999. 190: 1697-1710.
5. Gross, J. A., Dillon, S. R., Mudri, S., Johnston, J., Littau, A., Roque, R., Rixon, M. et al., TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease. Impaired B cell maturation in mice lacking BLyS. Immunity 2001. 15: 289-302.
6. Schiemann, B., Gommerman, J. L., Vora, K., Cachero, T. G., Shulga-Morskaya, S., Dobles, M., Frew, E. and Scott, M. L., An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. Science 2001. 293: 2111-2114.
7. Cheema, G. S., Roschke, V., Hilbert, D. M. and Stohl, W., Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases. Arthritis Rheum. 2001. 44: 1313-1319.
8. Krumbholz, M., Theil, D., Derfuss, T., Rosenwald, A., Schrader, F., Monoranu, C. M., Kalled, S. L. et al., BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma. J. Exp. Med. 2005. 201: 195-200.
9. Ohata, J., Zvaifler, N. J., Nishio, M., Boyle, D. L., Kalled, S. L., Carson, D. A. and Kipps, T. J., Fibroblast-like synoviocytes of mesenchymal origin express functional B cell-activating factor of the TNF family in response to proinflammatory cytokines. J. Immunol. 2005. 174: 864-870.
10. Zhang, J., Roschke, V., Baker, K. P., Wang, Z., Alarcon, G. S., Fessler, B. J., Bastian, H. et al., Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus. J. Immunol. 2001. 166: 6-10.
11. He, B., Chadburn, A., Jou, E., Schattner, E. J., Knowles, D. M. and Cerutti, A., Lymphoma B cells evade apoptosis through the TNF family members BAFF/BLyS and APRIL. J. Immunol. 2004. 172: 3268-3279.
12. Novak, A. J., Grote, D. M., Stenson, M., Ziesmer, S. C., Witzig, T. E., Habermann, T. M., Harder, B. et al., Expression of BLyS and its receptors in B-cell non-Hodgkin lymphoma: correlation with disease activity and patient outcome. Blood 2004. 104: 2247-2253.
13. Sasaki, Y., Casola, S., Kutok, J. L., Rajewsky, K. and Schmidt-Supprian, M., TNF family member B cell-activating factor (BAFF) receptor-dependent and -independent roles for BAFF in B cell physiology. J. Immunol. 2004. 173: 2245-2252.
14. Schneider, P., Takatsuka, H., Wilson, A., Mackay, F., Tardivel, A., Lens, S., Cachero, T. G. et al., Maturation of marginal zone and follicular B cells requires B cell activating factor of the tumor necrosis factor family and is independent of B cell maturation antigen. J. Exp. Med. 2001. 194: 1691-1697.
15. Shulga-Morskaya, S., Dobles, M., Walsh, M. E., Ng, L. G., MacKay, F., Rao, S. P., Kalled, S. L. and Scott, M. L., B cell-activating factor belonging to the TNF family acts through separate receptors to support B cell survival and T cell-independent antibody formation. J. Immunol. 2004. 173: 2331-2341.
16. Thompson, J. S., Bixler, S. A., Qian, F., Vora, K., Scott, M. L., Cachero, T. G., Hession, C. et al., BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF. Science 2001. 293: 2108-2111.
17. Seshasayee, D., Valdez, P., Yan, M., Dixit, V. M., Tumas, D. and Grewal, I. S., Loss of TACI causes fatal lymphoproliferation and autoimmunity, establishing TACI as an inhibitory BLyS receptor. Immunity 2003. 18: 279-288.
18. Yan, M., Wang, H., Chan, B., Roose-Girma, M., Erickson, S., Baker, T., Tumas, D. et al., Activation and accumulation of B cells in TACI-deficient mice. Nat. Immunol. 2001. 2: 638-643.
19. von Bulow, G. U., van Deursen, J. M. and Bram, R. J., Regulation of the T-independent humoral response by TACI. Immunity 2001. 14: 573-582.
20. Castigli, E., Wilson, S. A., Garibyan, L., Rachid, R., Bonilla, F., Schneider, L. and Geha, R. S., TACI is mutant in common variable immunodeficiency and IgA deficiency. Nat. Genet. 2005. 37: 829-834.
21. Salzer, U., Chapel, H. M., Webster, A. D., Pan-Hammarstrom, Q., Schmitt-Graeff, A., Schlesier, M., Peter, H. H. et al., Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nat. Genet. 2005. 37: 820-828.
22. Turner, C. A., Jr., Mack, D. H. and Davis, M. M., Blimp-1, a novel zinc finger-containing protein that can drive the maturation of B lymphocytes into immunoglobulin-secreting cells. Cell 1994. 77: 297-306.
23. Shapiro-Shelef, M. and Calame, K., Regulation of plasma-cell development. Nat. Rev. Immunol. 2005. 5: 230-242.
24. Litinskiy, M. B., Nardelli, B., Hilbert, D. M., He, B., Schaffer, A., Casali, P. and Cerutti, A., DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat. Immunol. 2002. 3: 822-829.
25. Zarnegar, B., He, J. Q., Oganesyan, G., Hoffmann, A., Baltimore, D. and Cheng, G., Unique CD40-mediated biological program in B cell activation requires both type 1 and type 2 NF-kappaB activation pathways. Proc. Natl. Acad. Sci. USA 2004. 101: 8108-8113.
26. Huang, X., Di Liberto, M., Cunningham, A. F., Kang, L., Cheng, S., Ely, S., Liou, H. C. et al., Homeostatic cell-cycle control by BLyS: Induction of cell-cycle entry but not G1/S transition in opposition to p181NK4c and p27Kip1. Proc. Natl. Acad. Sci. U A 2004. 101: 17789-17794.
27. Castigli, E., Wilson, S. A., Scott, S., Dedeoglu, F., Xu, S., Lam, K. P., Bram, R. J. et al., TACI and BAFF-R mediate isotype switching in B cells. J. Exp. Med. 2005. 201: 35-39.
28. Castigli, E., Scott, S., Dedeoglu, F., Bryce, P., Jabara, H., Bhan, A. K., Mizoguchi, E. and Geha, R. S., Impaired IgA class switching in APRIL-deficient mice. Proc. Natl. Acad. Sci. USA 2004. 101: 3903-3908.
29. Ingold, K., Zumsteg, A., Tardivel, A., Huard, B., Steiner, Q. G., Cachero, T. G., Qiang, F. et al., Identification of proteoglycans as the APRIL-specific binding partners. J. Exp. Med. 2005. 201: 1375-1383.
30. Hendriks, J., Planelles, L., de Jong-Odding, J., Hardenberg, G., Pals, S. T., Hahne, M., Spaargaren, M. and Medema, J. P., Heparan sulfate proteoglycan binding promotes APRIL-induced tumor cell proliferation. Cell Death Differ. 2005. 12: 637-648.
31. Couchman, J. R., Syndecans: proteoglycan regulators of cell-surface microdomains? Nat. Rev. Mol. Cell. Biol. 2003. 4: 926-937.
32. + peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. J. Exp. Med. 1998. 188: 1679-1689.
33. Keller, S., Braun, M. C., Tan, B. K., Rosenwald, A., Cordier, C., Conley, M. E., Plebani, A. et al., Human blood IgM "memory" B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire. Blood 2004. 104: 3647-3654.
34. Gatto, D., Ruedl, C., Odermatt, B. and Bachmann, M. F., Rapid response of marginal zone B cells to viral particles. J. Immunol. 2004. 173: 4308-4316.
35. Sharpe, A. H. and Freeman, G. J., The B7-CD28 superfamily. Nat. Rev. Immunol. 2002. 2: 116-126.
36. Hase, H., Kanno, Y., Kojima, M., Hasegawa, K., Sakurai, D., Kojima, H., Tsuchiya, N. et al., BAFF/BLyS can potentiate B-cell selection with the B-cell coreceptor complex. Blood 2004. 103: 2257-2265.
37. Hase, H., Kanno, Y., Kojima, H., Morimoto, C., Okumura, K. and Kobata, T., CD27 and CD40 inhibit p53-independendent mitochondrial pathways in apoptosis of B cells induced by B cell receptor ligation. J. Biol. Chem. 2002. 277: 46950-46958.
38. Morimoto, S., Kanno, Y., Tanaka, Y., Tokano, Y., Hashimoto, H., Jacquot, S., Morimoto, C. et al., CD134L engagement enhances human B cell Ig production: CD154/CD40, CD70/CD27, and CD134/CD134L interactions coordinately regulate T cell-dependent B cell responses. J. Immunol. 2000. 164: 4097-4104.